Institutional investors purchased a net $3.1 million shares of PBYI during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 103.56% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PARTNER FUND MANAGEMENT LP Bought 1.9 Million shares of Puma Biotechnology Inc
CUTLER GROUP LP Bought 37.1 Thousand shares of Puma Biotechnology Inc